T1	PROC 542 550	tratados
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 18 42	enfermedad renal crónica
#2	AnnotatorNotes T2	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T3	DISO 60 72	hipertensión
#3	AnnotatorNotes T3	C0020538; Hypertensive disease; Disease or Syndrome
T4	PROC 98 122	estrategias terapéuticas
#4	AnnotatorNotes T4	C0679624; medical treatment method; Therapeutic or Preventive Procedure (?)
T5	CHEM 144 161	diuréticos de asa
#5	AnnotatorNotes T5	C0354100; Loop Diuretics; Pharmacologic Substance
T6	CHEM 166 196	antagonistas de la aldosterona
#6	AnnotatorNotes T6	C0002007; Aldosterone Antagonists; Pharmacologic Substance
T7	DISO 306 327	hipertensión arterial
#7	AnnotatorNotes T7	C0020538; Hypertensive disease; Disease or Syndrome
T8	DISO 329 332	HTA
#8	AnnotatorNotes T8	C0020538; Hypertensive disease; Disease or Syndrome
T9	DISO 347 371	enfermedad renal crónica
#9	AnnotatorNotes T9	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T10	DISO 373 376	ERC
#10	AnnotatorNotes T10	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T11	PROC 428 439	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	PROC 562 586	estrategias terapéuticas
#12	AnnotatorNotes T12	C0679624; medical treatment method; Therapeutic or Preventive Procedure (?)
T13	DISO 500 503	ERC
#13	AnnotatorNotes T13	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T14	DISO 521 524	ERC
#14	AnnotatorNotes T14	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T15	DISO 527 530	HTA
#15	AnnotatorNotes T15	C0020538; Hypertensive disease; Disease or Syndrome
T16	PROC 599 610	tratamiento
#16	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	CHEM 635 645	furosemida
#17	AnnotatorNotes T17	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T18	PROC 729 732	FGe
#18	AnnotatorNotes T18	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T19	PROC 795 803	tratados
#19	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	CHEM 808 823	espironolactona
#20	AnnotatorNotes T20	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T21	CHEM 833 843	furosemida
#21	AnnotatorNotes T21	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T22	CHEM 990 1005	espironolactona
#22	AnnotatorNotes T22	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T23	CHEM 1047 1057	furosemida
#23	AnnotatorNotes T23	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T24	CHEM 1111 1126	espironolactona
#24	AnnotatorNotes T24	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T25	PROC 1130 1133	PAS
#25	AnnotatorNotes T25	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T26	CHEM 1181 1191	furosemida
#26	AnnotatorNotes T26	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T27	PROC 940 943	FGe
#27	AnnotatorNotes T27	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T28	PROC 1268 1279	tratamiento
#28	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	DISO 1310 1321	albuminuria
#29	AnnotatorNotes T29	C0001925; Albuminuria; Finding
T30	PROC 1391 1402	seguimiento
#30	AnnotatorNotes T30	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T31	CHEM 1427 1437	furosemida
#31	AnnotatorNotes T31	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T32	DISO 1441 1452	albuminuria
#32	AnnotatorNotes T32	C0001925; Albuminuria; Finding
T33	DISO 1497 1513	enfermedad renal
#33	AnnotatorNotes T33	C0022658; Kidney Diseases; Disease or Syndrome
T34	PROC 1558 1561	FGe
#34	AnnotatorNotes T34	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T35	DISO 1584 1595	albuminuria
#35	AnnotatorNotes T35	C0001925; Albuminuria; Finding
T36	DISO 1615 1632	diabetes mellitus
#36	AnnotatorNotes T36	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T37	PROC 1652 1663	tratamiento
#37	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	PROC 1697 1708	tratamiento
#38	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	DISO 1764 1775	albuminuria
#39	AnnotatorNotes T39	C0001925; Albuminuria; Finding
T40	PROC 1890 1901	tratamiento
#40	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	PROC 1936 1952	presión arterial
#41	AnnotatorNotes T41	C0005824; Blood pressure determination; Health Care Activity
T42	DISO 1958 1969	albuminuria
#42	AnnotatorNotes T42	C0001925; Albuminuria; Finding
T43	DISO 1987 1990	HTA
#43	AnnotatorNotes T43	C0020538; Hypertensive disease; Disease or Syndrome
T44	CHEM 2019 2029	furosemida
#44	AnnotatorNotes T44	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T45	DISO 2082 2085	ERC
#45	AnnotatorNotes T45	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T46	ANAT 29 34	renal
#46	AnnotatorNotes T46	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T47	ANAT 283 288	renal
#47	AnnotatorNotes T47	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T48	ANAT 319 327	arterial
#48	AnnotatorNotes T48	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T49	ANAT 358 363	renal
#49	AnnotatorNotes T49	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T50	CHEM 615 630	espironolactona
#50	AnnotatorNotes T50	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T51	PROC 758 761	PAS
#51	AnnotatorNotes T51	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T52	PROC 774 777	PAD
#52	AnnotatorNotes T52	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T53	PROC 845 853	seguidos
#53	AnnotatorNotes T53	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T54	PROC 1205 1208	PAD
#54	AnnotatorNotes T54	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T55	CHEM 1284 1299	espironolactona
#55	AnnotatorNotes T55	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T56	ANAT 1508 1513	renal
#56	AnnotatorNotes T56	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T57	PROC 1538 1541	PAS
#57	AnnotatorNotes T57	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T58	CHEM 1668 1683	espironolactona
#58	AnnotatorNotes T58	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T59	CHEM 1713 1728	espironolactona
#59	AnnotatorNotes T59	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T60	CHEM 1906 1921	espironolactona
#60	AnnotatorNotes T60	C0037982; spironolactone; Organic Chemical · Pharmacologic Substance
T61	ANAT 1944 1952	arterial
#61	AnnotatorNotes T61	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T62	Duration 35 42	crónica
#62	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	LIVB 46 55	pacientes
#63	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Date 212 228	En la actualidad
T65	LIVB 292 301	pacientes
#64	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Duration 364 371	crónica
#65	AnnotatorNotes T66	C0205191; chronic; Temporal Concept
T67	LIVB 507 516	pacientes
#66	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 671 680	pacientes
#67	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T70	Age 714 727	66,3±9,1 años
T73	Duration 881 889	32 meses
T74	Frequency 930 935	anual
T75	LIVB 1097 1106	pacientes
#68	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T76	Duration 891 896	28-41
T78	Neg_cue 1606 1608	no
T81	LIVB 1973 1982	pacientes
#69	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group
T82	Date 2086 2099	a largo plazo
T83	PHYS 275 288	función renal
#70	AnnotatorNotes T83	C0232804; Renal function; Organ or Tissue Function
A1	Assertion T36 Negated
R1	Negation Arg1:T78 Arg2:T36	
T69	Neg_cue 1453 1455	no
T71	CONC 1456 1465	descendió
A2	Assertion T71 Negated
#71	AnnotatorNotes T71	C0547047; Decrease; Quantitative Concept
R2	Negation Arg1:T69 Arg2:T71	
R3	Location_of Arg1:T46 Arg2:T2	
R4	Has_Duration_or_Interval Arg1:T2 Arg2:T62	
R5	Experiences Arg1:T63 Arg2:T2	
R6	Experiences Arg1:T63 Arg2:T3	
T72	Observation 1 42	Progresión de la enfermedad renal crónica
R7	Experiences Arg1:T63 Arg2:T72	
T77	Observation 73 83	resistente
#72	AnnotatorNotes T77	C3542449; Drug Resistance Status; Finding (?)
R8	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T77	
R9	Experiences Arg1:T63 Arg2:T77	
R11	Used_for Arg1:T5 Arg2:T4	
R12	Used_for Arg1:T6 Arg2:T4	
R10	Experiences Arg1:T63 Arg2:T4	
T79	CONC 259 268	evolución
#73	AnnotatorNotes T79	C0449259; Clinical course; Temporal Concept (?)
R13	Location_of Arg1:T47 Arg2:T83	
R14	Experiences Arg1:T65 Arg2:T83	
R15	Experiences Arg1:T65 Arg2:T7	
R16	Overlap Arg1:T83 Arg2:T7	
R17	Location_of Arg1:T48 Arg2:T7	
R18	Location_of Arg1:T48 Arg2:T8	
R20	Overlap Arg1:T2 Arg2:T3	
R21	Location_of Arg1:T49 Arg2:T9	
R22	Location_of Arg1:T49 Arg2:T10	
T80	Observation 334 344	resistente
#74	AnnotatorNotes T80	C3542449; Drug Resistance Status; Finding (?)
R23	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T80	
R24	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T80	
R25	Experiences Arg1:T65 Arg2:T80	
R26	Experiences Arg1:T65 Arg2:T9	
R27	Overlap Arg1:T8 Arg2:T9	
R19	Overlap Arg1:T7 Arg2:T10	
R28	Overlap Arg1:T7 Arg2:T9	
T84	Observation 449 459	progresión
#75	AnnotatorNotes T84	C1457868; Worse; Finding
R29	Experiences Arg1:T65 Arg2:T84	
R30	Before Arg1:T10 Arg2:T84	
R31	Before Arg1:T9 Arg2:T84	
R32	Before Arg1:T2 Arg2:T72	
R33	Experiences Arg1:T65 Arg2:T11	
T85	Observation 483 503	progresión de la ERC
R34	Before Arg1:T13 Arg2:T85	
R35	Experiences Arg1:T67 Arg2:T85	
R36	Experiences Arg1:T67 Arg2:T13	
R37	Experiences Arg1:T67 Arg2:T14	
R38	Before Arg1:T14 Arg2:T85	
R39	Overlap Arg1:T14 Arg2:T15	
R40	Overlap Arg1:T13 Arg2:T15	
R41	Experiences Arg1:T67 Arg2:T15	
T86	Observation 531 541	resistente
#76	AnnotatorNotes T86	C3542449; Drug Resistance Status; Finding (?)
R42	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T86	
R43	Experiences Arg1:T67 Arg2:T86	
R44	Experiences Arg1:T67 Arg2:T1	
R45	Experiences Arg1:T67 Arg2:T12	
R46	Experiences Arg1:T67 Arg2:T16	
R47	Used_for Arg1:T50 Arg2:T16	
R48	Used_for Arg1:T17 Arg2:T16	
R49	Used_for Arg1:T50 Arg2:T12	
R50	Used_for Arg1:T17 Arg2:T12	
R51	Used_for Arg1:T50 Arg2:T1	
R52	Used_for Arg1:T17 Arg2:T1	
R53	Has_Age Arg1:T68 Arg2:T70	
T87	Result_or_Value 733 756	55,8±16,5ml/min/1,73 m2
R54	Has_Result_or_Value Arg1:T18 Arg2:T87	
T88	Result_or_Value 762 771	162,8±8,2
R55	Has_Result_or_Value Arg1:T51 Arg2:T88	
T89	Result_or_Value 778 790	90,2±6,2mmHg
R56	Has_Result_or_Value Arg1:T52 Arg2:T89	
R57	Used_for Arg1:T20 Arg2:T19	
R58	Used_for Arg1:T21 Arg2:T19	
R59	Experiences Arg1:T68 Arg2:T18	
R60	Experiences Arg1:T68 Arg2:T51	
R61	Experiences Arg1:T68 Arg2:T52	
R62	Experiences Arg1:T68 Arg2:T19	
R64	Has_Duration_or_Interval Arg1:T53 Arg2:T73	
R65	Has_Duration_or_Interval Arg1:T53 Arg2:T76	
T90	Observation 915 923;936 943	descenso del FGe
#77	AnnotatorNotes T90	C4552444; Estimated glomerular filtration rate decreased; Finding
R66	Has_Frequency Arg1:T90 Arg2:T74	
R67	Has_Frequency Arg1:T27 Arg2:T74	
R68	Experiences Arg1:T75 Arg2:T24	
T91	Observation 1130 1143	PAS disminuyó
#78	AnnotatorNotes T91	C0277885; Decreased systolic arterial pressure; Finding 
R69	Experiences Arg1:T75 Arg2:T25	
R70	Experiences Arg1:T75 Arg2:T91	
R71	Experiences Arg1:T75 Arg2:T26	
T92	Observation 1205 1218	PAD se redujo
#79	AnnotatorNotes T92	C0277890; Decreased diastolic arterial pressure; Finding 
R72	Used_for Arg1:T55 Arg2:T28	
T93	Observation 1300 1321	redujo la albuminuria
R73	Causes Arg1:T28 Arg2:T93	
T94	CONC 1381 1402	final del seguimiento
R75	Overlap Arg1:T93 Arg2:T94	
T95	Observation 1470 1480;1491 1513	progresión en la enfermedad renal
R80	Location_of Arg1:T56 Arg2:T33	
R81	Location_of Arg1:T56 Arg2:T95	
T96	Quantifier_or_Qualifier 1562 1567	basal
#81	AnnotatorNotes T96	C1442488; Baseline; Quantitative Concept
R86	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T96	
R87	Overlap Arg1:T33 Arg2:T35	
R88	Overlap Arg1:T95 Arg2:T35	
R89	Overlap Arg1:T95 Arg2:T36	
R90	Overlap Arg1:T33 Arg2:T36	
R91	Used_for Arg1:T58 Arg2:T37	
R94	Used_for Arg1:T59 Arg2:T38	
T97	CONC 1850 1870	modelo multivariante
#82	AnnotatorNotes T97	C0026777; Multivariate Analysis; Quantitative Concept (?)
R96	Used_for Arg1:T60 Arg2:T40	
T98	Observation 1922 1928;1933 1952	reduce la presión arterial
R97	Location_of Arg1:T61 Arg2:T41	
R98	Location_of Arg1:T61 Arg2:T98	
R99	Causes Arg1:T40 Arg2:T98	
T99	Observation 1922 1928;1955 1969	reduce la albuminuria
R100	Experiences Arg1:T81 Arg2:T42	
R101	Before Arg1:T42 Arg2:T99	
R102	Experiences Arg1:T81 Arg2:T43	
R103	Experiences Arg1:T81 Arg2:T40	
R104	Experiences Arg1:T81 Arg2:T99	
R105	Experiences Arg1:T81 Arg2:T41	
R106	Experiences Arg1:T81 Arg2:T98	
R107	Overlap Arg1:T42 Arg2:T43	
R108	Experiences Arg1:T81 Arg2:T44	
T100	Observation 2055 2065;2076 2085	progresión de la ERC
R109	Overlap Arg1:T100 Arg2:T82	
R110	Before Arg1:T45 Arg2:T100	
R111	Experiences Arg1:T81 Arg2:T100	
R112	Experiences Arg1:T81 Arg2:T45	
R113	Overlap Arg1:T43 Arg2:T45	
R114	Causes Arg1:T40 Arg2:T100	
T101	Observation 1991 2001	resistente
#80	AnnotatorNotes T101	C3542449; Drug Resistance Status; Finding (?)
R115	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T101	
R116	Experiences Arg1:T81 Arg2:T101	
R117	Location_of Arg1:T46 Arg2:T72	
R118	Overlap Arg1:T8 Arg2:T10	
R63	Before Arg1:T24 Arg2:T91	
R119	Before Arg1:T26 Arg2:T91	
R74	Before Arg1:T37 Arg2:T95	
#83	AnnotatorNotes T82	C0443252; Long-term; Temporal Concept
#84	AnnotatorNotes T64	C0521116; Current (present time); Temporal Concept
#85	AnnotatorNotes T72	C0858257; Chronic renal failure worsened; Finding
#86	AnnotatorNotes T85	C0858257; Chronic renal failure worsened; Finding
#87	AnnotatorNotes T95	C0858257; Chronic renal failure worsened; Finding
#88	AnnotatorNotes T100	C0858257; Chronic renal failure worsened; Finding
A3	Experiencer T63 Patient
A4	Experiencer T65 Patient
A5	Experiencer T81 Patient
A6	Experiencer T75 Patient
A7	Experiencer T68 Patient
A8	Experiencer T67 Patient
R76	Has_Result_or_Value Arg1:T27 Arg2:T90	
R77	Has_Result_or_Value Arg1:T25 Arg2:T91	
R78	Has_Result_or_Value Arg1:T54 Arg2:T92	
R79	Has_Result_or_Value Arg1:T41 Arg2:T98	
